Journal Article

DKFZ-2022-01795

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Pediatric precision oncology-Time for clinical prime time.

Pfister, S. (First author)DKFZ* ; Witt, O.DKFZ* ; Jones, D. (Last author)DKFZ*

2022
Elsevier Amsterdam

This record in other databases:  

Please use a persistent id in citations: doi:10.1016/j.medj.2022.07.004

Abstract: Recent prospective molecular tumor-profiling studies in pediatric cancer patients across a variety of different healthcare systems have highlighted both the feasibility and clinical utility of this approach. The current study by Church and colleagues in Nature Medicine1 has further substantiated this and laid the groundwork for a systematic collaborative approach to pediatric precision oncology in the US.

Note: #EA:B062#LA:B360# / Note

---

Contributing Institute(s):

1. B062 Pädiatrische Neuroonkologie (B062)
2. DKTK HD zentral (HD01)
3. KKE Pädiatrische Onkologie (B310)
4. Pediatric Glioma (B360)

Research Program(s):

1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2022

---

Database coverage:
; Clarivate Analytics Master Journal List ; Emerging Sources Citation Index ; SCOPUS ; Web of Science Core Collection

---